Marcal Yll-Pico

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Body Mass Index

Dendritic Cells

Roux En Y Gastric Bypass

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Marcal Yll-Pico, Yoonsuh Park, Joy Martinez, Angelina Iniguez, Mindy Kha, Taehyun Kim, Leonard Medrano, Vu H Nguyen, Teodora Kaltcheva, Shannon Dempsey, Flavia Chiuppesi, Felix Wussow, Don J Diamond
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform. NPJ vaccines 9 (1) (2024)
Marcal Yll-Pico, Yoonsuh Park, Joy Martinez, Angelina Iniguez, Mindy Kha, Taehyun Kim, Leonard Medrano, Vu H Nguyen, Teodora Kaltcheva, Shannon Dempsey, Flavia Chiuppesi, Felix Wussow, Don J Diamond
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform. NPJ vaccines 9 (1) (2024)
Marcal Yll-Pico, Yoonsuh Park, Joy Martinez, Angelina Iniguez, Mindy Kha, Taehyun Kim, Leonard Medrano, Vu H Nguyen, Teodora Kaltcheva, Shannon Dempsey, Flavia Chiuppesi, Felix Wussow, Don J Diamond
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform. NPJ vaccines 9 (1) (2024)
Felix Wussow, Mindy Kha, Taehyun Kim, Minh Ly, Marcal Yll-Pico, Swagata Kar, Mark G Lewis, Flavia Chiuppesi, Don J Diamond
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants. NPJ vaccines 8 (1) (2023)
Felix Wussow, Mindy Kha, Taehyun Kim, Minh Ly, Marcal Yll-Pico, Swagata Kar, Mark G Lewis, Flavia Chiuppesi, Don J Diamond
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants. NPJ vaccines 8 (1) (2023)
Felix Wussow, Mindy Kha, Taehyun Kim, Minh Ly, Marcal Yll-Pico, Swagata Kar, Mark G Lewis, Flavia Chiuppesi, Don J Diamond
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants. NPJ vaccines 8 (1) (2023)